Hi All,
just spotted this one, not sure which thread would be most appropriate.
ImmunoGen: Consolidation in the pharmaceutical sector continues! US drugmaker ImmunoGen has agreed to be acquired by research-based pharmaceutical specialist AbbVie for $10.1 billion. AbbVie has thus strengthened its portfolio of cancer treatments, notably by acquiring Elahere, a blockbuster drug approved for ovarian cancer. The transaction is expected to close in mid-2024.
I haven’t had time to look any further however seems relevant to an IMU deal.
Hi All,just spotted this one, not sure which thread would be...
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.6¢ |
Change
0.001(2.22%) |
Mkt cap ! $342.1M | |||
| Open | High | Low | Value | Volume |
| 4.5¢ | 4.7¢ | 4.5¢ | $906.2K | 19.67M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 20 | 9543864 | 4.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.6¢ | 1266571 | 1 |
View Market Depth
| Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
| IMU (ASX) Chart |